These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18567961)

  • 1. Treatment practice and research issues in improving opioid treatment outcomes.
    Jackson TR
    Sci Pract Perspect; 2002 Jul; 1(1):22-8. PubMed ID: 18567961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response: the new environment of accountability for OTPs.
    Collins RL; Cornely W; Grella C
    Sci Pract Perspect; 2002 Jul; 1(1):28-9. PubMed ID: 18567962
    [No Abstract]   [Full Text] [Related]  

  • 3. Implementation of the methadone treatment quality assurance system. findings from the feasibility study.
    Ducharme LJ; Luckey JW
    Eval Health Prof; 2000 Mar; 23(1):72-90. PubMed ID: 10787952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing and Treating Narcotic Addiction--Century of Federal Drug Control.
    Courtwright DT
    N Engl J Med; 2015 Nov; 373(22):2095-7. PubMed ID: 26605925
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacotherapy of Opioid Addiction: "Putting a Real Face on a False Demon".
    Salsitz E; Wiegand T
    J Med Toxicol; 2016 Mar; 12(1):58-63. PubMed ID: 26567033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating the drug abuser.
    Doyle KM; Quinones MA; Louria DB
    Public Health Rev; 1982; 10(1):77-98. PubMed ID: 6813913
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.
    Soyka M; Hillemacher T
    Addiction; 2014 Jan; 109(1):88-9. PubMed ID: 24438113
    [No Abstract]   [Full Text] [Related]  

  • 9. Methadone in the chronic pain patient with a substance use disorder.
    Reisfield GM; Friedman CK
    J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):368-70. PubMed ID: 23216175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response: Still room to improve an effective treatment.
    Bickel WK; Gigelow G; Kampman K
    Sci Pract Perspect; 2005 Dec; 3(1):32-3. PubMed ID: 18552744
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine.
    Meteliuk A; Galvez de Leon SJ; Madden LM; Pykalo I; Fomenko T; Filippovych M; Farnum SO; Dvoryak S; Islam ZM; Altice FL
    J Subst Abuse Treat; 2021 Feb; 121():108164. PubMed ID: 33191004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of service use and treatment involvement of methadone maintenance patients.
    Widman M; Platt JJ; Lidz V; Mathis DA; Metzger DS
    J Subst Abuse Treat; 1997; 14(1):29-35. PubMed ID: 9218234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The case for a medication first approach to the treatment of opioid use disorder.
    Winograd RP; Presnall N; Stringfellow E; Wood C; Horn P; Duello A; Green L; Rudder T
    Am J Drug Alcohol Abuse; 2019; 45(4):333-340. PubMed ID: 31084515
    [No Abstract]   [Full Text] [Related]  

  • 14. Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
    Krawczyk N; Mojtabai R; Stuart EA; Fingerhood M; Agus D; Lyons BC; Weiner JP; Saloner B
    Addiction; 2020 Sep; 115(9):1683-1694. PubMed ID: 32096302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New hot topics sections: 1. China's new march forward in addiction treatment: methadone for the masses. 2. Issues in formulating DSM V.
    Kosten TR; Gardner TJ
    Am J Drug Alcohol Abuse; 2008; 34(2):123-6. PubMed ID: 18293228
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pros and cons of methadone?].
    Lôo H; Laqueille X
    Rev Prat; 2002 Oct; 52(15):1629-30. PubMed ID: 12434589
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of the Chinese police in methadone maintenance therapy: a literature review.
    Meng J; Burris S
    Int J Drug Policy; 2013 Nov; 24(6):e25-34. PubMed ID: 23623719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physicians practicing in methadone treatment programs: who are they and what do they do?
    Wechsberg WM; Flannery B; Kasten JJ; Suerken C; Dunlap L; Roussel AE; Crum L; Murdoch O; Diesenhaus H
    J Addict Dis; 2004; 23(2):15-31. PubMed ID: 15132340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Help Is on the Way: Medicare Coverage of Opioid Treatment Programs.
    Felix C; Sharfstein JM; Olsen Y
    J Am Geriatr Soc; 2020 Mar; 68(3):637-640. PubMed ID: 31825528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating opioid dependence. Growing implications for primary care.
    Krantz MJ; Mehler PS
    Arch Intern Med; 2004 Feb; 164(3):277-88. PubMed ID: 14769623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.